Sign in

You're signed outSign in or to get full access.

Mark Herpich

Executive Vice President and Chief Financial Officer at LANDMARK BANCORP
Executive

About Mark Herpich

Executive Vice President, Secretary & Chief Financial Officer of Landmark Bancorp, Inc. (and Landmark National Bank) since October 2001; previously VP/Secretary/Treasurer & CFO at MNB Bancshares/Security National Bank (1998–2001) and Senior Manager/CPA at KPMG LLP (1989–1998). Education: BS Accounting, Kansas State University; age 55 as disclosed in the company’s proxy (2023) . Recent operating results under his financial stewardship: Q1 2025 net income $4.7M, ROA 1.21%, ROE 13.71%, and net interest margin expanded to ~3.76% . Pay-versus-performance TSR illustrates $100 growing to ~$108.71 by FY2024; FY2024 net income $13,003K .

Past Roles

OrganizationRoleYearsStrategic Impact
Landmark Bancorp, Inc. / Landmark National BankEVP, Secretary & CFOOct 2001–PresentLong-tenured finance leadership through multiple rate cycles; CFO signatory for SEC certifications
MNB Bancshares / Security National BankVP, Secretary, Treasurer & CFOSep 1998–Oct 2001Held same positions prior to Landmark formation, continuity in bank finance leadership
KPMG LLPSenior Manager (CPA)Aug 1989–Sep 1998Public accounting, bank audits/controls—foundation for CFO role

External Roles

No public company directorships or committee roles disclosed for Herpich in company proxies. (No disclosure found in DEF 14A) .

Fixed Compensation

Metric20232024
Base Salary ($)280,000 289,054
Cash Bonus ($)45,630
All Other Compensation ($)26,397 30,154
Total ($)422,465 446,803

All other compensation components (disclosed details):

  • 2023: 401(k) company contribution $18,680; car allowance $930; country club dues $6,787
  • 2024: 401(k) company contribution $20,700; car allowance $2,335; country club dues $7,119

Performance Compensation

Annual cash incentive (non-equity):

Metric20232024
Non-Equity Incentive Plan Payout ($)30,420 68,588

Bonus performance metrics (set annually by Compensation Committee; weightings/targets not disclosed):

  • Earnings per share growth; specific asset quality goals; return on average assets goals

Equity awards – Restricted Stock (RSUs/Stock Awards):

GrantUnvested Shares (#)Vesting ScheduleMarket Value at 12/31/2024 ($24.01/sh)
08/01/2022907 25% annually beginning 08/01/2023 21,777
08/01/20243,090 25% annually beginning 08/01/2025 74,191

Equity awards – Stock Options:

Grant DateExercise Price ($)ExpirationExercisable (#)Unexercisable (#)
08/01/202719.80 08/01/2027 5,167
08/01/202917.50 08/01/2029 8,710
08/01/203122.83 08/01/2031 4,436 1,478 (25% annual vesting)
08/01/203319.20 08/01/2033 2,484 7,453 (25% annual vesting)

Equity grant mechanics:

  • Annual equity awards typically granted in August; grants approved on/before grant date; no timing around MNPI; 2024 plan approved May 22, 2024

Equity Ownership & Alignment

Ownership ItemAmount
Total beneficial ownership (shares)157,753
Percent of shares outstanding2.7% (based on 5,778,610 shares at 04/02/2025)
Options exercisable within 60 days20,797 shares
Restricted stock held (unvested)3,997 shares (25% vest annually over four years)
Jointly owned with spouse128,101 shares
IRA holdings4,858 shares
Shares pledged as collateral (red flag)24,093 shares (line of credit)

Alignment policies:

  • Anti-hedging policy prohibits hedging transactions by directors/officers/employees; insider trading policy in place .

Stock ownership guidelines:

  • No explicit executive stock ownership multiple disclosed in proxy (no disclosure found) .

Employment Terms

  • Agreement: Initial one-year term auto-renews annually; termination notice ≥90 days pre-anniversary .
  • Current base salary under agreement: $285,000 (subject to annual review) .
  • Incentives/Perquisites: Eligible for annual performance bonus (Committee-selected metrics), country club membership, car allowance, and executive benefits .
  • Non-compete/Non-solicit: 18 months post-termination for each executive .
  • Severance (assuming event as of 12/31/2024): Involuntary termination cash $374,356; medical $7,491; total $381,847. Change-in-control (covered period) cash $748,711; equity acceleration $133,560; medical $7,491; total $889,763 .
  • Change-of-control vesting: Under 2015 plan—full vest if plan not assumed; double-trigger vest (termination without cause or resignation for good reason within 24 months) if assumed; performance awards vest fractionally if <50% achieved, fully if ≥50% at COC . Under 2024 plan—full vest (same double-trigger construct); performance objectives deemed achieved at target upon qualifying events; death/disability acceleration for restricted stock .
  • Clawback: Adopted October 2023 per Nasdaq listing standards—recoup certain incentive compensation upon accounting restatements .
  • 280G Cutback: Severance reduced to $1 below threshold to preserve tax deductibility .

Performance & Track Record

MeasureLatest/PeriodNote
Net income$4.7M in Q1 2025Up from $2.8M in Q1 2024; improved NIM and lower expenses
Net interest margin (tax-equivalent)~3.76% Q1 2025+25 bps vs Q4 2024
ROA / ROE1.21% / 13.71% (Q1 2025)Efficiency ratio 64.1%
TSR proxy metric$100 → $108.71 (FY2024)Pay-versus-performance table
FY2024 net income$13,003KPay-versus-performance table

Operational execution notes:

  • Q1 2025 expense reductions linked to 2024 branch closures; decreased professional fees and occupancy .

Compensation Structure Analysis

  • Mix shift: 2024 non-equity incentive increased to $68,588 vs $30,420 in 2023, while equity grants (restricted stock) rose (3,090 shares granted in Aug 2024) .
  • Options vs RSUs: Herpich’s program includes multi-year option grants with 10-year expirations and 25% annual vesting; RSUs vest 25% annually—lower risk than options, but both present .
  • Performance metrics: EPS growth, asset quality, ROAA drive annual incentives; specific targets/weightings not disclosed .
  • Pledging: 24,093 pledged shares—misalignment risk if margin calls force sales (insider selling pressure) .

Equity Ownership & Alignment Details

ComponentVested vs Unvested
Options (multiple grants)20,797 exercisable within 60 days; remaining unexercisable vest 25% annually
Restricted stock907 (2022 grant) vesting 25% per year since 08/01/2023; 3,090 (2024 grant) vesting 25% per year starting 08/01/2025
Anti-hedgingHedging prohibited by policy

Employment Contracts, Severance & Change-of-Control Economics

Scenario (as of 12/31/2024)Cash Severance ($)Equity Acceleration ($)Medical ($)Total ($)
Involuntary Termination374,356 7,491 381,847
Covered Period (Change-in-Control)748,711 133,560 7,491 889,763
Death/Disability133,560 133,560

Change-in-control mechanics and clawback summarized above .

Governance, Say-on-Pay & Policies

  • Say-on-Pay: At the 2022 annual meeting, ~84% votes approved NEO compensation (triennial frequency set; advisory vote held again in 2025) .
  • Code of Conduct and Insider Trading policy enforced; anti-hedging prohibition; disclosures posted on corporate governance site .

Investment Implications

  • Alignment: Annual bonus tied to EPS growth, asset quality, and ROAA aligns CFO incentives with core bank performance drivers; increased 2024 payout suggests strong metric attainment . RSUs with 4-year vesting further promote retention .
  • Insider selling pressure risk: 24,093 pledged shares pose potential forced-sale risk in adverse markets; monitor Form 4 filings for any pledge-related transactions and sell-to-cover at vesting dates (next major RSU tranche 25% on 08/01/2025) .
  • Change-in-control economics: Double-trigger vesting and substantial cash severance during the COC covered period could influence behavior around strategic transactions; equity acceleration at target under 2024 plan reduces uncertainty for performance awards .
  • Execution credibility: CFO certifications, improved NIM, expense control from branch rationalization, and strong Q1 2025 ROA/ROE support operational discipline—positive for pay-for-performance linkage and confidence in forecasts .
  • Monitoring list: Weightings/targets for annual incentive are not disclosed; continue tracking proxy updates for metric calibration; verify continued compliance with anti-hedging and any changes to pledging policies .